Related Experiment Videos

Differences in physician utilization between Aboriginal and non-Aboriginal children

P S Ho1, T N Wang, T K Hsieh

  • 1School of Public Health, Kaohsiung Medical University, Pingdong County, Taiwan, Republic of China.

Family Practice
|October 6, 2000
PubMed

Insights

Aboriginal children face significant barriers to healthcare access, including lower health insurance coverage and challenges reaching medical services. These factors contribute to higher rates of medical injections and delayed treatment compared to non-Aboriginal children.

Area of Science:

  • Public Health
  • Indigenous Health
  • Pediatrics

Background:

  • Healthcare access disparities persist for Indigenous populations globally.
  • Understanding factors influencing medical practitioner visits is crucial for equitable healthcare delivery.
  • Previous research indicates unique challenges faced by Aboriginal children in accessing healthcare services.

Purpose of the Study:

  • To investigate factors influencing medical practitioner visits among Aboriginal children.
  • To compare healthcare utilization patterns between Aboriginal and non-Aboriginal children.
  • To identify barriers to healthcare access for Aboriginal children.

Main Methods:

  • A comparative study design was employed, surveying children from selected Aboriginal and non-Aboriginal communities.
  • A door-to-door survey methodology was used, collecting data from children born after 1983.
  • A total of 896 children (316 Aboriginal, 580 non-Aboriginal) completed the questionnaire, ensuring a high response rate.

Main Results:

  • Non-Aboriginal children exhibited higher national health insurance coverage compared to Aboriginal children.
  • Aboriginal parents were more likely to seek out-of-community medical practitioners for sick children.
  • Aboriginal children experienced a higher frequency of medical injections.

Conclusions:

  • Lower national health insurance coverage is a significant issue for Aboriginal children.
  • Difficulties in accessing medical resources, including travel time and distance, pose major problems.
  • Higher rates of intramuscular injections suggest potential differences in treatment approaches or access to primary care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...